These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21525339)

  • 1. Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.
    SenGupta D; Tandon R; Vieira RG; Ndhlovu LC; Lown-Hecht R; Ormsby CE; Loh L; Jones RB; Garrison KE; Martin JN; York VA; Spotts G; Reyes-Terán G; Ostrowski MA; Hecht FM; Deeks SG; Nixon DF
    J Virol; 2011 Jul; 85(14):6977-85. PubMed ID: 21525339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.
    de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF; Michaud HA
    Retrovirology; 2017 Aug; 14(1):41. PubMed ID: 28830571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
    Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell responses to human endogenous retroviruses in HIV-1 infection.
    Garrison KE; Jones RB; Meiklejohn DA; Anwar N; Ndhlovu LC; Chapman JM; Erickson AL; Agrawal A; Spotts G; Hecht FM; Rakoff-Nahoum S; Lenz J; Ostrowski MA; Nixon DF
    PLoS Pathog; 2007 Nov; 3(11):e165. PubMed ID: 17997601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.
    Ormsby CE; Sengupta D; Tandon R; Deeks SG; Martin JN; Jones RB; Ostrowski MA; Garrison KE; Vázquez-Pérez JA; Reyes-Terán G; Nixon DF
    PLoS One; 2012; 7(8):e41021. PubMed ID: 22879884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.
    Jones RB; John VM; Hunter DV; Martin E; Mujib S; Mihajlovic V; Burgers PC; Luider TM; Gyenes G; Sheppard NC; Sengupta D; Tandon R; Yue FY; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    Clin Vaccine Immunol; 2012 Feb; 19(2):288-92. PubMed ID: 22205657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.
    Tandon R; SenGupta D; Ndhlovu LC; Vieira RG; Jones RB; York VA; Vieira VA; Sharp ER; Wiznia AA; Ostrowski MA; Rosenberg MG; Nixon DF
    J Virol; 2011 Nov; 85(21):11526-31. PubMed ID: 21880743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukemia antigen-A*0201-restricted epitopes of human endogenous retrovirus W family envelope (HERV-W env) induce strong cytotoxic T lymphocyte responses.
    Tu X; Li S; Zhao L; Xiao R; Wang X; Zhu F
    Virol Sin; 2017 Aug; 32(4):280-289. PubMed ID: 28840564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dominant ex vivo cross-stimulation of CD8+ T-cells with whole soluble gag protein in HIV-infected subjects.
    Tavernier A; Jennes W; Fransen K; De Roo A; Kestens L
    J Acquir Immune Defic Syndr; 2006 Apr; 41(5):548-56. PubMed ID: 16652028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
    Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
    J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes.
    Mullins CS; Linnebacher M
    Cancer Immunol Immunother; 2012 Jul; 61(7):1093-100. PubMed ID: 22187063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
    Jones RB; Leal FE; Hasenkrug AM; Segurado AC; Nixon DF; Ostrowski MA; Kallas EG
    J Negat Results Biomed; 2013 Jan; 12():3. PubMed ID: 23305161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus?
    Morandi E; Tanasescu R; Tarlinton RE; Constantin-Teodosiu D; Gran B
    Front Immunol; 2018; 9():3092. PubMed ID: 30740110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population.
    Kaushik S; Vajpayee M; Wig N; Seth P
    Clin Exp Immunol; 2005 Nov; 142(2):388-97. PubMed ID: 16232229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection.
    Feeney ME; Draenert R; Roosevelt KA; Pelton SI; McIntosh K; Burchett SK; Mao C; Walker BD; Goulder PJ
    J Immunol; 2003 Dec; 171(12):6968-75. PubMed ID: 14662905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection.
    Ramduth D; Day CL; Thobakgale CF; Mkhwanazi NP; de Pierres C; Reddy S; van der Stok M; Mncube Z; Nair K; Moodley ES; Kaufmann DE; Streeck H; Coovadia HM; Kiepiela P; Goulder PJ; Walker BD
    PLoS One; 2009; 4(4):e5013. PubMed ID: 19352428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.
    Jennes W; Camara M; Dièye T; Mboup S; Kestens L
    J Virol; 2008 Sep; 82(17):8619-28. PubMed ID: 18562522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.